Taubman Scholar Dr. Arul Chinnaiyan featured in Medical News Today

Dr. Arul Chinnaiyan, a Taubman Scholar and the director of the Michigan Center for Translational Pathology, is featured in a recent Medical News Today article.  The story outlines the work he's doing -- along with other U-M researchers and physicians -- to use genetic sequencing as a means of matching cancer patients  with the most appropriate clinical trial. 

Patients, for example, whose cancer is resisting conventional treatment could be quickly matched with an experimental trial based on the gene mutations discovered in the analysis. 

 

 

Read the Medical News Today article

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

Watch the Video